You Searched For "Rossari Biotech IPO review" and got 13 results
Sort By:
2 mins read
Rossari Biotech is hiring — and the company’s average salary is ₹10 lakh per year
The Mumbai-based speciality chemical maker Rossari Biotech is looking to hire more people as it exp…
1 min read
Stellar listing for Rossari Biotech - stock price surges over 16% on listing day
The ₹496 crore IPO of Rossari Biotech had a bumper listing today. The stock added nearly 16.4% in a…
5 mins read
Top stock movers — Future Enterprises, HAL, Suntek, Oberoi Realty, M&M, ICICI Bank, Maruti Suzuki, Bajaj Auto and more
Indian benchmark stock index, Sensex advanced over 175 points in early trade on Thursday, led by fi…
3 mins read
We've reviewed dozens of successful pitch decks amid healthcare's private funding boom. Here's what they all have in common.
These are Insider's biggest healthcare stories for the week ending December 10.
Leah Rosenbaum,Megan Hernbroth
2 mins read
AIIMS Delhi to start clinical trial of Covaxin on children aged 6-12 years from Tuesday
The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children…
3 mins read
The digital health startups that are ripe for an IPO
These are Business Insider's biggest healthcare stories for November 2.
Megan Hernbroth
5 mins read
A second primary-care company is gearing up to go public
These are the top stories written by Business Insider's healthcare team for the week ending July 17.
Lydia Ramsey Pflanzer
2 mins read
After Happiest Minds Tech, Route Mobile doubles the money invested in the IPO
The cloud communication platform services provider, Route Mobile, made a strong debut on the bourse…
4 mins read
Barbeque Nation IPO must be priced the same way as its menu—value for money
The company will use the IPO proceeds to repay an outstanding loan of ₹205 cro…
4 mins read
Morgan Stanley says Moderna could double after the biotech's massive wipeout in 2018
Other investors have been more skeptical of Moderna's success. When sharing her 2019 predictions, V…
Lydia Ramsey,Emma Court
8 mins read
10 surprises that could rock biotech stocks in 2019, from success in Alzheimer's to a stumble in depression
Sage Therapeutics's depression treatment, Sage-217, acts on GABA, one of the neurotransmitters in t…
Lydia Ramsey
2 mins read
Biotech companies have been raising billions by going public -but many investors are getting burned
Which is to say, not every bet is panning out, despite record amounts of capital being poured into …
Lydia Ramsey
3 mins read
A top investor at Pfizer's $1 billion VC arm reveals the 2 biggest mistakes startup biotechs make when trying to win her cash
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…